Abstract

Abstract:

The present invention relates to crystalline form of (Z)-11-[3­(dimethylamino) propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid represented by the following structural formula-1, which is referred to as Olopatadine.

Formula-1

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS